MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0262917

Медицинская библиотека · PloS one · 2022

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV.

Morsica Giulia, Galli Laura, Messina Emanuela, Castagna Antonella, Bagaglio Sabrina, Salpietro Stefania, Liviana Della Torre, Uberti-Foppa Caterina, Hasson Hamid

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The dynamic of HIV-viral load (VL) remains poorly investigated in HIV/HCV patients under direct acting antivirals (DAAs).

METHODS

We retrospectively evaluated HIV-VL at baseline (BL) during and up to 24 weeks post-DAAs in a cohort of 305 HIV-1/HCV patients, on ART and with no HIV virological failure (VF) in the 6 months before treatment with DAAs; during the period of observation VF was defined as confirmed VL≥50 copies/mL; virological blips (VB, transient, not confirmed, VL ≥50 copies/mL). Stepwise Cox regression models were fitted to estimate adjusted hazard ratios (aHR) of VF.

RESULTS

Fifteen VF occurred in 13 patients over 187 person-years of follow-up (PYFU): incidence rate (IR) of 8.0 per 100-PYFU (95% CI = 4.0-12.1); 29 VBs were detected in 26 patients over 184 PYFU: IR = 15.8 per 100-PYFU (95% CI = 10.0-21.5). The most prominent factor associated with VF was the presence of BL HIV residual viremia (RV = HIV-RNA detectable but not precisely quantifiable) [aHR = 12.26 (95% CI = 3.74-40.17), P<0.0001]. Other factors were ≥1 VBs in the 6 months before DAAs [aHR = 6.95 (95% CI = 1.77-27.37) P = 0.006] number of ART regimens failed before DAAs initiation [aHR (per more regimen) = 1.22 (95% CI = 1.04-1.42), P = 0.012] and age [aHR (per year older) = 1.16 (95% CI = 1.04-1.29), P = 0.010].

CONCLUSIONS

Our findings underline the importance for close monitoring HIV-VL in selected patients. Whether this phenomenon is triggered by the rapid clearance of HCV remains to be established.

Для цитирования: Morsica Giulia, Galli Laura, Messina Emanuela, Castagna Antonella, Bagaglio Sabrina, Salpietro Stefania, Liviana Della Torre, Uberti-Foppa Caterina, Hasson Hamid. Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV.. PloS one. 2022. DOI: 10.1371/journal.pone.0262917.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.